A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways.
- Author(s)
- Anderson, RP; Henry, MJ; Taylor, R; Duncan, EL; Danoy, P; Costa, MJ; Addison, K; Tye-Din, JA; Kotowicz, MA; Knight, RE; Pollock, W; Nicholson, GC; Toh, BH; Brown, MA; Pasco, JA;
- Details
- Publication Year 2013-08-28,Volume 11,Issue #1,Page 188
- Journal Title
- BMC Medicine
- Publication Type
- JOURNAL ARTICLE
- Abstract
- Changing perspectives on the natural history of celiac disease (CD), new serology and genetic tests, and amended histological criteria for diagnosis cast doubt on past prevalence estimates for CD. We set out to establish a more accurate prevalence estimate for CD using a novel serogenetic approach.
- Publisher
- BioMed Central
- Keywords
- Celiac disease; Diagnosis; Epidemiology; Serology; Transglutaminase; Deamidated gliadin peptide; Immunogenetics; Prevalence
- Research Division(s)
- Immunology
- Publisher's Version
- https://doi.org/10.1186/1741-7015-11-188
- Open Access at Publisher's Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765645/- Terms of Use/Rights Notice
- © 2013 Anderson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creation Date: 2013-08-28 12:00:00